Lasa Supergenerics Share Price

Lasa Supergenerics Share Price

  • 7.680.09 (1.06%)
  • Live
  • As On: 18 Jun, 2026, 11:32 AM IST
Loading...
Open7.60
High7.95
Low7.41
Prev Close7.60
Volume19,598
VWAP(₹)7.67

Key Metrics

PE Ratio(x)-1.13
EPS - TTM(₹)-6.80
MCap(₹ Cr.)38.53
MCap Rank104
PB Ratio(x)0.77
Div Yield(%)-
Face Value(₹)10.00
52W High(₹)14.08
52W Low(₹)5.67
MCap/Sales1.13
Beta(1 Month)0.92
BV/Share(₹)9.90

Lasa Supergenerics share price insights

  • Undertaking New Debt

    Company has outstanding debt obligations for the first time in last 5 years. (Source: Standalone Financials)
  • PAT: Troublesome Times

    Company has posted a loss of Rs 4.16 cr for the 4th consecutive quarter. (Source: Standalone Financials)
  • Employee & Interest Expense

    Company has spent 1.54% of its operating revenues towards interest expenses and 8.63% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
  • Lasa Supergenerics Share Price Update

    Lasa Supergenerics Ltd. share price moved up by 1.06% from its previous close of Rs 7.60. Lasa Supergenerics Ltd. stock last traded price is 7.68

    Share PriceValue
    Today/Current/Last7.68
    Previous Day7.60

Found Insights useful?

Lasa Supergenerics Share Price Returns

1 Day1.06%
1 Month-0.26%
3 Months5.35%
1 Year-29.61%
3 Years-66.46%
5 Years-90.55%

Lasa Supergenerics Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Share Analysis

EARNINGS
FUNDAMENTAL
RELATIVE VALUATION
RISK
PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

  • Score on 10-point scale
  • Ratings by analysts
  • Stock performance
JOIN ET PRIME

Financials

  • Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
    Total Income-0.092.223.0720.1541.53
    Total Income Growth (%)-104.10-27.73-84.77-51.4925.01
    Total Expenses3.764.528.6342.6663.54
    Total Expenses Growth (%)-16.81-47.66-79.77-32.86136.73
    EBIT-3.85-2.30-5.56-22.51-22.01
    EBIT Growth (%)-----444.87
    Profit after Tax (PAT)-4.16-2.55-6.25-21.12-14.29
    PAT Growth (%)-----360.13
    EBIT Margin (%)0.00-103.72-181.26-111.75-53.00
    Net Profit Margin (%)0.00-115.22-203.77-104.83-34.41
    Basic EPS (₹)-0.83-0.51-1.25-4.22-2.85
    FY 2026FY 2025FY 2024FY 2023FY 2022
    Total Revenue25.34147.46104.43131.37137.18
    Total Revenue Growth (%)-82.8241.20-20.51-4.24-32.23
    Total Expenses38.91151.17114.77153.74135.53
    Total Expenses Growth (%)-74.2631.72-25.3513.43-21.63
    Profit after Tax (PAT)-34.09-14.76-21.73-38.62-5.37
    PAT Growth (%)-----123.56
    Operating Profit Margin (%)-52.44-0.71-8.05-14.051.23
    Net Profit Margin (%)-135.59-10.35-20.82-29.80-3.91
    Basic EPS (₹)-6.80-2.95-4.34-7.71-1.30

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • PAT: Troublesome Times

      Company has posted a loss of Rs 4.16 cr for the 4th consecutive quarter. (Source: Standalone Financials)
    • Employee & Interest Expense

      Company has spent 1.54% of its operating revenues towards interest expenses and 8.63% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Total Assets66.27101.53150.87163.86199.21
    Total Assets Growth (%)-34.73-32.70-7.93-17.75-4.16
    Total Liabilities16.6517.8254.1945.5750.57
    Total Liabilities Growth (%)-6.57-67.1218.92-9.893.33
    Total Equity49.6283.7196.68118.29148.63
    Total Equity Growth (%)-40.72-13.42-18.27-20.41-6.47
    Current Ratio (x)0.621.900.780.921.65
    Total Debt to Equity (x)0.200.000.000.000.00
    Contingent Liabilities0.00----

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Undertaking New Debt

      Company has outstanding debt obligations for the first time in last 5 years. (Source: Standalone Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Net Cash flow from Operating Activities-0.07-2.822.14-17.3010.49
    Net Cash used in Investing Activities0.348.15-0.4011.19-3.25
    Net Cash flow from Financing Activities-0.25-5.66-1.93-4.16-0.04
    Net Cash Flow0.01-0.33-0.19-10.277.20
    Closing Cash & Cash Equivalent0.290.280.610.8011.04
    Closing Cash & Cash Equivalent Growth (%)4.54-54.77-23.88-92.76187.62
    Total Debt/ CFO (x)-132.260.000.000.000.00

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Return on Equity (%)-68.69-17.62-22.47-32.65-3.61
    Return on Capital Employed (%)-26.63-1.21-8.24-15.031.08
    Return on Assets (%)-51.44-14.53-14.40-23.57-2.69
    Interest Coverage Ratio (x)-18.564.191.17-1.15389.33
    Asset Turnover Ratio (x)0.301.130.660.710.67
    Price to Earnings (x)-0.83-5.72-5.07-2.40-31.65
    Price to Book (x)0.571.011.140.781.14
    EV/EBITDA (x)-5.237.4247.93-18.829.71
    EBITDA Margin (%)-28.507.912.17-3.6911.44

    No Data Available

    Insights
    • Losing Shareholder's Money

      Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)

Found Financials useful?

Technicals

Peer Comparison

Shareholding Pattern

  • CategoryNo. of SharesPercentage% Change QoQ
    Promoters2,68,79,65053.65 %0.00
    Pledge55,53,64920.66 %0.00
    FII2,34,7200.47 %0.45
    Others2,29,86,86946.35 %0.00
  • CategoryMar 2026Dec 2025Sep 2025Jun 2025
    Promoters53.6553.6553.6553.65
    Pledge20.6620.6620.6620.66
    FII0.000.000.000.47
    DII0.000.000.000.00
    Mutual Funds0.000.000.000.00
    Others46.3546.3546.3545.88

Mutual Funds Ownership

No Data Available

Corporate Actions

  • Board Meeting

    Audited Results

    May 19, 2026

    Board Meeting

    Quarterly Results

    Feb 03, 2026

    Board Meeting

    Quarterly Results

    Nov 06, 2025

  • Announced onMeeting on
    May 19, 2026May 29, 2026
    Audited Results
    Feb 03, 2026Feb 13, 2026
    Quarterly Results
    Nov 06, 2025Nov 14, 2025
    Quarterly Results
    Aug 05, 2025Aug 13, 2025
    Quarterly Results
    May 26, 2025May 28, 2025
    Audited Results
  • Announced onEx-DateDividend%
    Apr 11, 2022Sep 16, 20222%
    May 31, 2021Sep 15, 20212%
  • No Data Available

  • No Data Available

  • No Data Available

  • Announced onMeeting on
    Sep 15, 2025Sep 30, 2025
    -
    Aug 01, 2025Sep 04, 2025
    -
    Jan 30, 2025Feb 22, 2025
    -
    Sep 10, 2024Sep 27, 2024
    A.G.M.
    Sep 05, 2023Sep 27, 2023
    A.G.M.

About Lasa Supergenerics

Key Indices Listed On

-

Address

Plot No C-4, C-4/1, MIDC,Lote Parshuram Industrial Area,Tal: Khed,Ratnagiri Dist., Maharashtra - 415722

Executive Leadership

OP

Omkar Pravin Herlekar

Chairman & Managing Director
PC

Prathamesh Chalke

Whole Time Director
KB

Ketan Bhau Songal

Independent Director
PG

Pravin Gadalya Lachake

Independent Director
Show More

Auditors

Gupta Rustagi & Co
Thanawala & Co.

FAQs about Lasa Supergenerics share

  • 1. What is Lasa Supergenerics share price and what are the returns for Lasa Supergenerics share?
    Lasa Supergenerics share price is Rs 7.68 as on 18 Jun, 2026, 11:32 AM IST. Lasa Supergenerics share price is up by 1.06% based on previous share price of Rs. 7.44.
  • 2. What is the market cap of Lasa Supergenerics?
    Lasa Supergenerics share has a market capitalization of Rs 38.53 Cr. Within Chemicals sector, it's market cap rank is 104.
  • 3. What are the returns for Lasa Supergenerics share?
    Return Performance of Lasa Supergenerics Shares:
    • 1 Week: Lasa Supergenerics share price moved up by 6.96%
  • 4. What is Lasa Supergenerics's 52 week high / low?
    52 Week high of Lasa Supergenerics share is Rs 14.08 while 52 week low is Rs 5.67
  • 5. What is the PE & PB ratio of Lasa Supergenerics?
    The PE ratio of Lasa Supergenerics stands at -1.12, while the PB ratio is 0.77.

Top Gainers

As on 12:02 PM | 18 Jun 2026
New India Assurance
185.82
20.36 (12.31%)
FSN E-Comm (Nykaa)
302.10
21.16 (7.53%)
Star Health
570.05
36.35 (6.82%)
Carborundum Uni
1,202.90
72.61 (6.43%)
Redington
262.97
14.06 (5.65%)

Top Losers

As on 12:02 PM | 18 Jun 2026
IFCI
84.76
-5.31 (-5.90%)
IDBI Bank
85.95
-4.41 (-4.89%)
Elecon Engg Co
537.40
-21.25 (-3.81%)
Chennai Petro
1,128.00
-37.10 (-3.19%)
Suven Pharma
412.30
-12.85 (-3.03%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.